Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05624099
What this trial is testing

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Who this might be right for
Esophageal NeoplasmsEsophageal DiseasesDigestive System Neoplasms
Fujian Cancer Hospital 75
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Testing effectiveness (Phase 2)Ended earlyNCT01832857
What this trial is testing

Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients

Who this might be right for
Cancer
Cornerstone Pharmaceuticals 7
Testing effectiveness (Phase 2)Study completedNCT01757171
What this trial is testing

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal AdenocarcinomaDistal Esophageal Adenocarcinoma
Weill Medical College of Cornell University 85
Not applicableStudy completedNCT03434834
What this trial is testing

OCT Pilot in Esophagus

Who this might be right for
Barrett Esophagus
Duke University 53
Testing effectiveness (Phase 2)Study completedNCT05104567
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Who this might be right for
Oesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more
Sanofi 138
Early research (Phase 1)Ended earlyNCT00101907
What this trial is testing

Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer

Who this might be right for
Lung CancerPancreatic CancerEsophageal Cancer
Amgen 41
Early research (Phase 1)Ended earlyNCT01143545
What this trial is testing

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Who this might be right for
Lung CancerEsophageal CancerMalignant Pleural Mesothelioma+2 more
National Cancer Institute (NCI) 10
Not applicableStudy completedNCT03448341
What this trial is testing

Dysphagia Assessment After Swallowing Sparing RadioTherapy

Who this might be right for
Cancer of OropharynxCancer of Nasopharynx
Azienda Ospedaliero, Universitaria Pisana 74
Testing effectiveness (Phase 2)Looking for participantsNCT07385001
What this trial is testing

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaIvonescimabNeoadjuvant
Tang-Du Hospital 45
Not applicableNot Yet RecruitingNCT07440212
What this trial is testing

Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging

Who this might be right for
Esophagus Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 50
Testing effectiveness (Phase 2)Study completedNCT01443065
What this trial is testing

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

Who this might be right for
Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach
UNICANCER 162
Testing effectiveness (Phase 2)Study completedNCT00197444
What this trial is testing

Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer

Who this might be right for
Esophageal CancerSquamous Cell Carcinoma
Hamamatsu University 33
Not applicableLooking for participantsNCT04075305
What this trial is testing

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Who this might be right for
OncologyBreast CancerProstate Cancer+35 more
UMC Utrecht 8,000
Not applicableStudy completedNCT03787537
What this trial is testing

Nutritional Status and Nutrient Supply in Hospitalised Surgical Patients

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer
Charite University, Berlin, Germany 128
Testing effectiveness (Phase 2)Study completedNCT05964361
What this trial is testing

First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients

Who this might be right for
Esophageal CancerPancreas CancerOvarian Cancer+1 more
University Hospital, Antwerp 10
Post-approval studies (Phase 4)UnknownNCT04269369
What this trial is testing

Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients

Who this might be right for
Colon CancerStomach TumorAnal Tumor+2 more
Jessa Hospital 250
Large-scale testing (Phase 3)Study completedNCT00652769
What this trial is testing

A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST)

Who this might be right for
Bronchogenic Carcinoma
University College London Hospitals 168
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Not applicableEnded earlyNCT03540953
What this trial is testing

Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis

Who this might be right for
Esophageal StenosisDeglutition DisordersHead and Neck Neoplasms+1 more
Fauze Maluf Filho 12
Next Page